In the original article, Boulland et al. ([@B94]) and Carbonelle-Puscian et al. ([@B95]) were not cited in the article. These references have now been inserted in Mechanisms of Tumor Microenvironment Mediated Immune Evasion and Tumor Progression in NHL, **Paragraph Number 2**:

Inhibitory enzymes, like indolediamine oxidase (IDO), and phenylalanine oxidase interleukin 4-induced gene 1 (IL4I1), secreted by lymphoma associated macrophages and some B-NHL cells also contributes to immune suppression by Treg expansion and inhibition of effector T cell proliferation and activity ([@B94], [@B95]).

The citations for Boulland et al. ([@B94]) and Carbonelle-Puscian et al. ([@B95]) have also been inserted in the legend for Figure 1:

IDO and IL4I1 are also responsible for recruitment and differentiation of immunosuppressive Tregs, as well as exhaustion of T-effector cells through CCL22, TGF-β, and IL-12 secretion. FAS Ligand (FASL) induces apoptosis of CTLs ([@B94], [@B95]).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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